Darunavir
- Strength
- 800 mg/1
- Form
- Tablet, Film Coated
- Class
- Protease Inhibitor
Viona Pharmaceuticals Inc
Listed by Zydus Lifesciences Limited
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Protease Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 70771-1746 |
| FDA application | ANDA214085 |
| RxNorm concept | 670026 |
| Package sizes listed | 3 |
| Marketed since | May 2024 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Viona Pharmaceuticals Inc
Camber Pharmaceuticals, Inc.
Dr.Reddys Laboratories Inc
American Health Packaging
Camber Pharmaceuticals, Inc.
Zydus Lifesciences Limited
Novadoz Pharmaceuticals LLC
Viona Pharmaceuticals Inc
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.